Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
92.63%
-
Total 13F principal
-
$378,391,801
-
Principal change
-
-$1,068,000
-
Total reported market value
-
$351,177,625
-
Number of holders
-
47
-
Value change
-
-$492,626
-
Number of buys
-
15
-
Number of sells
-
16
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q1 2019
As of 31 Mar 2019,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
47 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$378,391,801
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, WELLS FARGO & COMPANY/MN, Southpaw Asset Management LP, ARISTEIA CAPITAL LLC, INCOME RESEARCH & MANAGEMENT, AXA, OAKTREE CAPITAL MANAGEMENT LP, STATE STREET CORP, and Capital World Investors.
This page lists
47
institutional bondholders reporting positions
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.